China holds roundtable with over 50 foreign pharmaceutical firms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts SNY Hot Sheet
Join SI Premium – FREE
Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.
The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.
Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's Muse AI to counter China models with subscribers, not ads, Alexandr Wang says - Nikkei
- General Dynamics names Amy Johnson as president of GDIT
- FDA approves first once-weekly insulin for type 2 diabetes mellitus in pediatric patients
Create E-mail Alert Related Categories
InvestingRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
